Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging
Author(s) -
Edwin Leeansyah,
Paul Cameron,
Ajantha Solomon,
Surekha Tennakoon,
Pushparaj Velayudham,
Maëlenn Gouillou,
Tim Spelman,
Anna C. Hearps,
Christopher K. Fairley,
De Villiers Smit,
Anna Pierce,
Jude Armishaw,
Suzanne M. Crowe,
David A. Cooper,
Kersten K. Koelsch,
JunPing Liu,
John Chuah,
Sharon R. Lewin
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit006
Subject(s) - abacavir , telomerase , lamivudine , zidovudine , peripheral blood mononuclear cell , emtricitabine , reverse transcriptase , virology , reverse transcriptase inhibitor , telomere , stavudine , biology , immunology , in vitro , virus , sida , viral disease , polymerase chain reaction , hepatitis b virus , dna , biochemistry , genetics , gene
Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related complications. We hypothesized that nucleos(t)ide reverse transcriptase inhibitors (NRTI) may contribute to accelerated aging in HIV-infected individuals on cART via inhibition of telomerase activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom